GlassScriptPhysician profile
Amanda G Combs
NPI 1881133585
$6,761.62
in general payments reported to CMS, 2019-2025
34 companies · $2,160 in 2025
The $2,160 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $487 · 2022: $824 · 2023: $1,263 · 2024: $2,028 · 2025: $2,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,450.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,029.18 | 2021-2025 | |
| Novo Nordisk INC | $1,013.23 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $595.28 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $524.91 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $347.79 | 2024-2025 | Caplyta |
| Pfizer INC. | $323.95 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $292.93 | 2021-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $273.99 | 2022-2025 | |
| Lilly USA, LLC | $251.33 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $241.64 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $198.81 | 2022-2025 | Otezla, Repatha, Evenity |
| Janssen Pharmaceuticals, INC | $191.98 | 2024-2025 | Spravato |
| Axsome Therapeutics, INC. | $191.33 | 2024-2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $164.73 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $161.24 | 2022-2025 | Quviviq, Quviviq |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.